Send to a Friend Font Size: Increase Decrease

ADAG and INCY Related Headlines

Apr 2, 2026 07:01AM Adagene partners with Incyte for cancer drug combination study
Apr 2, 2026 07:01AM Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable

ADAG and INCY Related Press Releases

Apr 2, 2026 07:01AM Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable

ADAG and INCY Related SEC Filings